Companies rush to roll out jabs specific to Omicron strain
2022-01-02
ICMR started research to study the efficacy of Covishield and Covaxin against the Omicron coronavirus variantMUMBAI: The highly-transmissible Omicron variant has triggered a flurry of activity globally, with at least 10 vaccine companies developing shots specific to the variant. An additional seven potential candidates under development are also being tested against the variant. Some of…Continue Reading